We succeeded in producing human gamma interferon (IFN-?) in tobacco protoplasts in quantity using genetically engineered brome mosaic virus (BMV strain ATCC66). This strain of BMV produces two types of coat protein, a full-length coat protein (20K) and a truncated coat protein (19K) which are translated from the first and second initiation codons, respectively. We replaced the truncated coat protein gene with the IFNy gene and synthesized BMV-IFN-7 chimera RNAs using an in vitro transcription system. The BMV-IFN-y chimera RNAs were used to inoculate tobacco protoplasts together with BMV RNA 1 and RNA 2 and produced IFN-y to a level of 5 to 10 % of total extracted proteins per infected protoplast after 24 h of incubation. The efficient production of IFN-? was attributed to the high translation activity of the BMV-IFN-y chimera RNA. We demonstrate that 24 nucleotides coding for the N-terminal amino acids of the full-length coat protein were probably involved in the high translation activity of the BMV-IFN-y chimera RNA.
Introduction
The potential use of plant viral RNAs as expression vectors for foreign genes has been reported for brome mosaic virus (BMV) (French et al., 1986) , tobacco mosaic virus (TMV) (Takamatsu et al., 1987; Donson et al., 1991) and barley stripe mosaic virus (BSMV) (Joshi et al., 1990) using reporter genes such as chloramphenicol acetyltransferase (CAT), neomycin phosphotransferase and firefly luciferase. In those systems, however, the level of protein production from foreign genes is low compared with that from the intrinsic viral genes for which the foreign genes are substituted.
The BMV genome consists of three separate RNAs (Lane, 1981) . RNA 1 (3.2kb) and RNA 2 (2.9kb) encoding proteins la and 2a respectively are required for RNA replication (French et al., 1986; Kiberstis et al., 1981) . Neither the putative movement protein 3a encoded by RNA 3 (2.1 kb) nor the coat protein encoded by subgenomic RNA 4 (0"9 kb) transcribed from RNA 3 (Miller et al., 1985) are required for viral RNA replication. So any viral RNA segment, including chimeric RNAs bearing a foreign gene, should be amplified by co-inoculation with RNA 1 and RNA 2 providing the RNA contains sequences required for replication (French & Ahlquist, 1987 Marsh et al., 1988) .
The strain ATCC66 of BMV used in this study produces two types of coat protein: a full-length coat protein (20K), designated CP1, and a truncated coat protein (19K), designated CP2, which are translated from the first and second initiation codons, respectively . We replaced viral genes for la, 2a, 3a, CP1 and CP2 with a human interferon gamma (IFN-y) gene using biologically active cDNA clones of BMV and obtained various BMV-IFN-y chimera RNAs using the in vitro transcription system. These BMV-IFN-y chimera RNAs were tested in tobacco protoplasts for their ability to be replicated and to produce IFN-7 by inoculation with RNA 1 and RNA 2. We found that a chimera RNA with the CP2 gene replaced by a foreign gene is replicated most efficiently and produced the foreign protein. We also discuss the post-translational modification and biological activity of IFN-y produced in tobacco protoplasts.
Methods

Construction of transcriptional vectors for BMV-IFN-y chimera
RNAs. Plasmids pBTF1, -2 and -3 which contain BMV full-length cDNA1, -2 and -3 linked to the T7 promoter (Moil et al., 1991) were used for construction of transcriptional vectors for BMV IFN-? chimera RNAs. To replace viral genes encoding la, 2a, 3a and coat proteins CP1 and CP2 with the IFN-y gene, a NsiI site was introduced into initiation codons in each of the coding regions of BMV cDNAs and the IFN-y gene by the method of Kunkel et al. (1987) using oligonucleotides 5' pd GTTTTTCACCAACAAAATGCATAGTTC-TATCGATTTGC for the la gene in pBTF1, 5' pd CACCAAGAT-GCATTCGAAAACC for the 2a gene in pBTF2, 5' pd GTTCCCGAT-GCATAACATAGTTT for the 3a gene in pBTF3, 5' pd GTATTTAATGCATACTTCAGGAAC for the CP1 gene in pBTF3, 5' pd TGGTAAGATGCATCGCGCGCAGC for the CP2 gene in pBTF3 and 5' pdTCTCTCGGAATGCATGCATGAAATATAC for the IFN-y gene in pMKC-15 (kindly provided by Dai-ichi Pharma-ceutical), creating pBTF 1 a, pBTF2a, pBTF3a, pBTFpCP 1, pBTFpCP2 and pUCplFN-Nsi, respectively.
Immediately downstream from a termination codon in pUCplFNNsi, a SacI site was introduced using oligonucleotide 5' pd CCCAGTAATGGAGCTCCTGCCTGC, creating pUCIFN-Nsi. pBTF3a was cut with Clal [nucleotide (nt) 600] and StuI (nt 1776), made blunt-ended with T4 DNA polymerase and then ligated with SacI linkers. The plasmid was cut with SacI and self-ligated, thereby removing intercistronic sequences and introducing a SacI site at the ClaI (nt 600) site, creating pBTF3al, pBTF3 was cut with SacI (nt 1473) and Stul (nt 1776), made blunt-ended with T4 DNA polymerase, and then self-ligated, thus removing a NsiI (nt 1717) site, creating pBTF3a2, pBTF3a2 was cut with Clal (nt 600), made blunt-ended with T4 DNA polymerase and then ligated with SacI linkers. The plasmid was cut with SacI and self-iigated, thus introducing a SacI site at the ClaI site, creating pBTF3a3, pBTFpCP 1 and pBTFpCP2 were cut with StuI (nt 1776) and ligated with SaeI linkers. The plasmids were cut with SacI and self-ligated, thus introducing a SacI site at the StuI site (nt 1776), creating pBTFCP1 and pBTFCP2, respectively. The larger fragments of NsiI/SacI-cut pBTF2a, pBTF3al, pBTF3a3, pBTFCP1 and pBTFCP2 were ligated with the Nsil/SacI fragment of the IFN-7 gene from pUCIFN-Nsi, creating pBTF2apIFN, pBTF3alpIFN, pBTF3a3pIFN, pBTFCPlpIFN and pBTFCP2pIFN, respectively.
The large fragment of NruI-(nt 2626)/NsiI-cut pBTFla was ligated with a SacI/NsiI-cut fragment of PUCIFN-Nsi in which the SacI site had been made blunt-ended with T4 DNA polymerase before NsiI treatment, creating pBTFlapIFN, pBTFlapIFN, pBTF2apIFN, pBTF3alpIFN, pBTF3a3pIFN, pBTFCPlpIFN and pBTFCP2pIFN were cut with NsiI, made blunt-ended with T4 DNA polymerase and self-ligated, creating pBTFlaIFN, pBTF2aIFN, pBTF3alIFN, pBTF3a3IFN, pBTFCPIIFN and pBTFCP2IFN. The larger fragments of BglII/EcoRI-cut pBTF3a3IFN were ligated with a smaller fragment of BglII-(nt 1220)/EcoRI-cut pBTF3, creating pBTF3a4IFN. pBTF3a4 was cut with BssHI (nt 1279), made blunt-ended with T4 DNA polymerase and self-ligated, thus introducing a frameshift into the BMV coat protein gene, creating pBTF3a5IFN.
Construction of transcriptional vectors for BMV-fl-glucuronidase (GUS) chimera RNAs. We replaced CP1 and CP2 genes with the GUS gene by the same method used for the construction of BMV-IFN-7 chimera RNAs. A NsiI site and a SacI site were introduced at the initiation and termination codons of the GU S gene in pBI 101 (Clontech Laboratories) using oligonucleotides 5' pd GTGGTCAGTCATGCAT-GTTACGTC and 5' pd AATGAATCAAGAGCTCTCCTGGCG, respectively, creating pUCGUS-Nsi. Transcriptional vectors pBTFCP1GUS and pBTFCP2GUS were constructed by the same method for pBTFCPIIFN and PBTFCP2IFN except that pUCGUSNsi was used instead of pUCIFN-Nsi.
Construction of transcriptional vectors for RNA 4 and CP2 genereplaced BMV IFN-? chimera RNA 4. Plasmid pBTF4 which contains BMV full-length cDNA 4 linked to the T7 promoter was used for the construction of a transcriptional vector for BMV-IFN-7 chimera RNA 4. The large fragment of Sall/EcoRI-cut pBTF4 was ligated with a small fragment of SalI/EcoRI-cut pBTFCP2IFN, creating pBTFsCP2IFN.
In vitro transcription and protoplast inoculation. Plasmids carrying the full-length BMV cDNA derivatives were linearized at an EcoRI site immediately downstream from the BMV sequence and used as templates for in vitro run-off transcription from the T7 promoter as described (Mori et al. 1991) . Protoplasts isolated from Nicotiana tabacum cv. Petit Habana (SR1) were inoculated with in vitro transcripts as described (Mori et al., 1992) . Approximately 105 protoplasts were collected after 24 h of incubation and used for further analysis.
RNA isolation and Northern blot analysis. RNA was isolated from protoplasts as described (Chomczynski & Sacchi, 1987) . The RNA was denatured in formaldehyde/formamide and fractionated on a 1.5 % agarose gel containing 1.8% formaldehyde and transferred to a Biodyne membrane. BMV RNAs and BMV-IFN-7 chimera RNAs were detected by a 32P-labelled SP6 transcript obtained from a subclone containing the 200 base HindIII (nt 1914)/EcoRI 3'-terminal fragment of BMV RNA 3 cDNA, which is conserved among all BMV RNAs. To detect BMV-GUS chimera RNAs we used a 32P-labelled SP6 transcript obtained from a subclone containing the 240-base NsiI (nt 1)/SnaBI (nt 240) fragment of pUCGUS-Nsi.
Protein analysis. Total protein was extracted from protoplasts with Laemmli's buffer (Laemmli, 1970) , and separated on a 15% polyacrylamide gel containing 0.1% SDS. Western blot analysis was carried out as described (Towbin et al., 1979) . Electrophoresed proteins were transferred to an Immobilon-P transfer membrane (Millipore) and probed with antiserum against IFN-y. The protein concentration of the plant extracts was determined by the dye-binding method of Bradford (1976) with a kit supplied by Bio-Rad Laboratories.
Deglycosylation of . N-Glycanase from Flavobacterium meningosepticum was used for the digestion of IFN-7 produced in tobacco protoplasts. Protoplast extracts (20 gl) were denatured at 100 °C for 5 min in 0.05 M-Tri~HC1 buffer pH 7.5, containing 0.5 % SDS, 50 mm-2-mercaptoethanol, 50 mM-EDTA. After cooling, 20 ~tl of 7.5 % NP40, 2.4 ~tl (0-6 unit) of N-glycanase and 27.6 ~tl of distilled water were added to the solution and incubated at 37 °C for 16 h. Samples were analysed on a 15 % SDS-polyacrylamide gel in parallel with an undigested control.
IFN-7 assay.
The antiviral activity of IFN-)~ was assayed by measuring the inhibition of cytopathic effects caused by Sindbis virus in human FL cells as described (Miyata et al., 1986) .
In vitro translation. In vitro translation of BMV-IFN-7 chimera RNA 4 was performed using wheatgerm extract (Amersham) as described . Radiolabelled polypeptides were separated on a 15% SDS-polyacrylamide gel. The gel was treated with ENLIGHTNING (Du Pont) for fluorography and exposed to a Fuji New RX film at -70 °C.
Results
BMV-IFN-7 and BMV-GUS chimera RNAs
Various BMV-IFN-7 or BMV-GUS chimera cDNAs were constructed by replacing the la, 2a, 3a, CP1 and CP2 genes with the IFN-7 or GUS gene (Fig. 1) . BMV-IFN-? chimera RNAs transcribed from the EcoRI-cut pBTFlaIFN, pBTF2aIFN, pBTF3alIFN, pBTF3a4IFN, pBTF3a5IFN, pBTFCPIIFN and pBTFCP2IFN by T7 RNA polymerase were designated FlaIFN, F2aIFN, F3alIFN (an intercistronic sequence deficient mutant), F3a4IFN, F3a5IFN (a coat protein frameshift mutant), FCPIIFN and FCP2IFN, respectively (Fig. 1 b) . Similarly BMV-GUS chimera RNAs obtained from pBTFCP1GUS and pBTFCP2GUS were designated FCP 1 GUS and FCP2GUS, respectively (Fig.  It,) .
Replication of BMV IFN-7 chimera RNAs
BMV-IFN-7 chimera RNAs were tested for their ability to be replicated in tobacco protoplasts following coinoculation with RNA 1 and RNA 2 transcripts. Total RNAs extracted from protoplasts were analysed by the Northern blot method using a probe specific for the 3' end of the BMV genome. Results in Fig. 2(a) show that F3a4IFN, F3a5IFN, FCPIIFN and FCP2IFN replicated and directed synthesis of the subgenomic mRNA whereas FlaIFN, F2aIFN and F3alIFN failed to replicate. Immunofluorescent staining with antiserum against IFN-y showed that in 5 to 10 % of the protoplasts inoculated with FCP2IFN IFN-~ accumulated to a detectable level (data not shown). The infection level was similar to that with RNA 3 as assessed by antiserum against coat protein (data not shown). Subgenomic mRNA transcribed from FCP2IFN accumulated to approximately 1% of the total extracted RNA per infected protoplast (data not shown).
Analysis of IFN-7 produced in tobacco protoplasts
IFN-7 produced in tobacco protoplasts was analysed by Western blotting using antiserum against IFN-y. IFN-7 accumulated in three different fractions with MrS of approximately 23K, 18K and 14-5K when protoplasts were inoculated with F3a4IFN, F3a5IFN, FCPIIFN and FCP2IFN. Among these RNAs FCP2IFN produced IFN-y to the highest level, approximately six-fold greater than that produced by FCPIIFN (Fig 2b) . The amount of IFN-7 produced by FCP2IFN was estimated to be approximately 0'5 % of the total extracted proteins by comparing the signal observed with those obtained for standard IFN-7 (Fig. 3) . This represents 5 to 10 % if the percentage of infected protoplasts is taken into consideration.
Analysis of glycosylation of lFN-)~ in tobacco protoplasts
IFN-7 produced in animal cells consists of three doublet components (of approximately 25K, 20K and 15K) when analysed by SDS-PAGE (Miyata et al., 1986) . The 25K
and 20K proteins are glycosylated and the 15K one is a minor component, probably non-glycosylated. IFN-7 produced in tobacco protoplasts similarly gave three doublet bands (of approximately 23K, 18K and 14.5K). The Mrs of each component were different from those of IFN-y produced in animal cells (Fig. 2b) . To investigate the glycosylation of IFN-~ produced in tobacco protoplasts, crude protein extracts from protoplasts inoculated with FCP2IFN combined with RNA 1 and RNA 2 were treated with N-glycanase and analysed by the Western blot method. Signals corresponding to the 23K, IFN-7 seemed to shift to a 14.5K protein after treatment with N-glycanase (Fig. 4) . This suggested that the 23K IFN-7 was deglycosylated, but the 18K and 14.5K proteins were not deglycosylated. These results revealed that IFN-7 can be glycosylated in tobacco protoplasts. Posttranslational modification at the N a n d / o r C termini of the protein seemed to differ between plant and animal cells.
Analysis of the biological activity of IFN-7 produced in tobacco protoplasts
Proteins were extracted from FCP2IFN-inoculated protoplasts. The extract containing IFN-~, at a concentration of approximately 10 ~tg/mg was assayed for the antiviral activity of IFN-7 by measuring the inhibition of cytopathic effects caused by Sindbis virus in human FL cells as described (Miyata et al., 1986) . The protein extract had an activity of 4 x 104 international units (IU)/mg, and protein extracts from mock-inoculated protoplasts had 8 x 102 IU/mg. These results indicate that IFN-y produced in tobacco protoplasts had an antiviral activity of approximately 4 x l0 G IU/mg.
Analysis of the replication of BMV-GUS chimera RNAs and the production of GUS in tobacco protoplasts
The CP1 and CP2 gene-replaced BMV-GUS chimera RNAs designated FCP1GUS and FCP2GUS, respectively, were tested for their ability to replicate and to produce GUS in tobacco protoplasts co-inoculated with RNA 1 and RNA 2. Both FCP1GUS and FCP2GUS replicated, with subgenomic m R N A being produced to the same extent (Fig. 5 a) . However, GUS was detected only in protoplasts inoculated with FCP2GUS (Fig. 5 b) . A fluorometric assay for GUS using 4-methylumbelliferyl fl-D-glucuronide showed that the amount of GUS produced from FCP2GUS was approximately 30-fold the level of that produced from FCP1GUS (data not shown).
In vitro translation of B M V -I F N p chimera RNA 4
BMV strain ATCC66 produces two types of coat protein from the first and second initiation codons of the coat protein gene . Therefore FCP2IFN was expected to produce two types of IFN-~, a coat proteinfusion IFN-y and an authentic IFN-7. We used an in vitro translation system to study this because the N-
panied by a minor band with lower electrophoretic mobility (Fig. 6 ). The alteration of the second AUG to AUU in FsCP2IFN resulted in an increase in this minor band, with no product migrating to the position of the main product from FsCP2IFN (unpublished results). These results indicate that FsCP2IFN mainly produced the authentic IFN-y translated from the second initiation codon, whereas BMV RNA 4 produced approximately the same amount of CP1 and CP2 (Fig. 6 ). terminal signal peptide of the IFN-y is likely to be processed in vivo thereby making it difficult to determine the ratio between the two types of IFN-7. BMV R N A 4 with the IFN-7 gene replacing the CP2 gene (FsCP2IFN, Fig. 1 b) was synthesized in vitro from the transcriptional vector pBTFsCP2IFN and was tested in a wheatgerm extract to analyse its translation products. BMV RNA 4 was used as the control. FsCP2IFN mainly produced I F N p with a faster electrophoretic mobility accom-
Discussion
The results presented here showed that BMV RNA 3 in which the CP2 gene was replaced with the I F N p gene produced IFN-7 to approximately 10% of total extractable proteins in infected tobacco protoplasts coinoculated with RNAs 1 and 2. A similar approach using the Russian strain of BMV has been reported for the expression of the CAT gene (French et al., 1986) . It is difficult to compare the two systems as regards the level of foreign gene expression and protein production since the foreign genes and protoplasts used are different and the accumulated levels of CAT are based only on its activity. A major difference between the two systems is that we used the CP2 gene for expressing a foreign gene instead of the full-length coat protein (CP1) gene used in the previous work by French et al. (1987) . The production of IFN-), and GUS from the CP2 gene-replaced chimera RNA 3 was six-and 30-fold of that from the CP1 genereplaced chimera RNA 3, respectively, although RNA replication of these chimera RNA 3s did not differ in transfected tobacco protoplasts. In addition, the translation activity of the CP1 or CP2 gene-replaced GUS or IFN chimera RNA 4 in wheatgerm extract resembled that of RNAs in vivo (unpublished results). These results suggest that 24 nt that code for the N-terminal eight amino acids of CP1 are required for the efficient translation of inserted foreign genes in chimera RNA 4 both in vivo and in vitro. However, a BMV mutant with the N-terminal 24 nt of the coat protein gene deleted allows translation to start at the initiation codon of the CP2 gene in the Russian strain of BMV and has normal infectivity in host plants (Sacher & Ahlquist, 1989) . Therefore it is suggested that nucleotide sequences encoding the N-terminal region of either the viral coat or foreign proteins are closely involved in determining the translation efficiency of BMV RNA 4 and its mutant derivatives.
It is known that the sequences adjacent to initiation codons influence the translation efficiency of mRNA (Kozak, 1991) . The translation of CP1 of BMV ATCC66 is influenced by a single nucleotide change in the 3' flanking position of the first AUG ).
However, it should be noted that BMV ATCC66 lacks two adjacent adenine residues in the leader sequence of the coat protein gene in RNA 4 . This might affect translation of foreign proteins such as IFNand GUS from the first AUG in FCPIlFN and FCP1GUS.
The comparison of the replication activities of various chimera RNAs used here provides us with further insight into the replication properties of each segmented genomic RNA of BMV. FlaIFN, F2aIFN and F3alIFN failed to replicate and/or accumulate in transfected protoplasts. This was true for similar types of BMV-GUS chimera RNAs (data not shown). Although accumulation levels of chimera RNAs in protoplasts will be affected by both the replication activity and the stability of the RNA, F3alIFN was expected not to replicate because of the lack of intercistronic sequences which are required for efficient amplification of RNA 3 (French & Ahlquist, 1987) . The replication of FlaIFN and F2aIFN are likely to be affected by inserted sequences since protein coding sequences in BMV RNA 2 are thought to be involved in RNA replication (Marsh et al., 1991) although no information is available for RNA 1.
The initiation codon of IFN-7, which is the second initiation codon in FCP2IFN, was predominantly used for the translation of IFN-y from the subgenomic chimera RNA 4. This indicates that the majority if IFNy synthesized from FCP2IFN was an authentic IFN-7 rather than the coat protein-fusion IFN-7. This unexpected feature of FCP2IFN will be useful for practical applications of this system in the future.
IFN-~ produced in tobacco protoplasts retained its biological activity, but post-translational modifications in the N-and/or C-terminal regions of IFN-~, or glycosylation, seem to vary between plant and animal cells. The activity of IFN-7 produced in tobacco protoplasts (approximately 4x 10~IU/mg) was low compared to that of IFN-? in animal cells (4.3 x 107 to 12 x 107 IU/mg (Miyata et al., 1986) . This may be due to infrequent glycosylation of IFN-7 in plant cells (Fig.  4) . Further purification of the IFN-7 produced in plant cells will be required for making an exact comparison of these IFN-7 activities.
